This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Pregnancy and Fibrinogen Disorders (FIBRINOGEST)
Clinical trial

Pregnancy and Fibrinogen Disorders (FIBRINOGEST)

Read time: 3 mins
Last updated:1st Sep 2019
Identifier: NCT03920332

Brief Summary:
The aim of this observational study is to evaluate the prevalence of uncomplicated pregnancies in women suffering from congenital fibrinogen disorders (i.e, hypofibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia) as well as to describe pregnancies outcomes in such diseases.

Detailed Description:
Women with quantitative or qualitative fibrinogen disorders are often more prone to obstetrical complications, from bleeding to recurrent miscarriages or thrombosis. Data on fibrinogen levels variations throughout the pregnancy and on the delivery management are lacking. In this observational study will be include adult women with pas obstetrical history. A general questionnaire on demographics and clinical data will be filled out by the patient's physician. A detailed questionnaire on obstetrical data will also be completed contacting the patient in case of lacking data.


Study Type: Observational
Estimated Enrollment: 200 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Obstetric Outcomes of Women Suffering From Hereditary Fibrinogen Disorders
Estimated Study Start Date: September 1, 2019
Estimated Primary Completion Date: March 1, 2021
Estimated Study Completion Date: September 1, 2021

Category Value
Date last updated at source 2019-04-18
Study type(s) Observational study
Expected enrolment 200
Study start date 2019-09-01
Estimated primary completion date 2021-03-01

View full details